| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |